Alkermes PLC
Records under this name other than patents Alkermes PLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to Alkermes PLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,980,652 | Compositions and Methods for Subcutaneous Administration of Cancer Immunotherapy Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,945,870 | Immunomodulatory IL-2 Agents in Combination with Immune Checkpoint Inhibitors Formerly held In force · High confidence | In force | High confidence | |
| US 11,834,483 | Immunostimulatory Agents in Combination with Angiogenesis Inhibitors Formerly held In force · High confidence | In force | High confidence | |
| US 12,338,293 | Upar Antibodies and Fusion Proteins with the Same Formerly held In force · High confidence | In force | High confidence | |
| US 11,246,906 | Compositions and Methods for Subcutaneous Administration of Cancer Immunotherapy Formerly held Lapsed on the fee record Ended Feb 15, 2026 · High confidence | Lapsed on the fee record | Ended Feb 15, 2026 | High confidence |
| US 11,248,050 | Immunomodulatory IL-2 Agents in Combination with Immune Checkpoint Inhibitors Formerly held Lapsed on the fee record Ended Feb 15, 2026 · High confidence | Lapsed on the fee record | Ended Feb 15, 2026 | High confidence |